Gallbladder NeoplasmsGallbladderGallbladder DiseasesDeoxycytidineGallbladder EmptyingAntimetabolites, AntineoplasticPancreatic NeoplasmsCholecystitisCholecystectomyCholecystographyCholelithiasisAntineoplastic Combined Chemotherapy ProtocolsImino AcidsBiliary Tract NeoplasmsGallstonesDeoxycytidine KinaseCholecystolithiasisTechnetium Tc 99m DisofeninNeoplasmsAdenocarcinomaLung NeoplasmsBileCholecystectomy, LaparoscopicTreatment OutcomeCisplatinDrug Administration ScheduleCholecystitis, AcuteCarcinoma, Pancreatic DuctalCystic DuctPolypsCholecystokininInfusions, IntravenousBile Duct NeoplasmsNeoplasm StagingEquilibrative Nucleoside Transporter 1Carcinoma, Non-Small-Cell LungCell Line, TumorAcalculous CholecystitisTechnetium Tc 99m LidofeninNeoplasms, Cystic, Mucinous, and SerousCarcinomaVinblastinePaclitaxelDrug Resistance, NeoplasmNeoplasm MetastasisMaximum Tolerated DoseDose-Response Relationship, DrugSurvival RateCA-19-9 AntigenTaxoidsLiver NeoplasmsCommon Bile DuctAntineoplastic AgentsDisease-Free SurvivalUrinary Bladder NeoplasmsCholangiocarcinomaSkin NeoplasmsBile Ducts, ExtrahepaticBiliary TractImmunohistochemistryDrug SynergismXenograft Model Antitumor AssaysKidney NeoplasmsNecturusBiliary DyskinesiaNeoplasms, Multiple PrimarySphincter of OddiFluorouracilLead RadioisotopesCombined Modality TherapyRibonucleoside Diphosphate ReductaseOrganoplatinum CompoundsRetrospective StudiesUrologic NeoplasmsTomography, X-Ray ComputedMice, NudeNeutropeniaOvarian NeoplasmsCarcinoma, Transitional CellIncidental FindingsDNA, NeoplasmPrognosisCarboplatinDisease ProgressionAdenomyomaCholangiopancreatography, Magnetic ResonanceRadiation-Sensitizing AgentsBile Ducts, IntrahepaticAdenocarcinoma, MucinousTumor Markers, BiologicalAdenocarcinoma, PapillaryTorsion AbnormalityBile Acids and SaltsNeoplasm InvasivenessSincalideTime FactorsNecturus maculosusNeoplasms, Second PrimaryGastrointestinal NeoplasmsChoristoma